Presentation JIM 2019

GP IIb/IIIa inhibitors are still the best option

Presenter: Alberto Menozzi

February 15, 2019

REGISTER for free or LOG IN to view this content

GP IIb/IIIa inhibitors are still the best option

Clinical Cardiology

Clinical Pharma

Coronary

CAD Pharma

Presentation

JIM 2019

PCI

GP IIb/IIIa inhibitors

Up Next

Presentation JIM 2019

Interventional and Pharmacological Crossroads: our decision

Presenter: Marco Ferlini

February 15, 2019

More slides +

Presentation

Stress Testing vs CT Angiography in Patients With Suspected CAD

February 25, 2019

Presentation

Natural History of SCAD With Spontaneous Angiographic Healing

February 27, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.